Trial intelligence / Profile preview

Intravenous fentanyl versus erector spinae block for chest trauma pain

IRCT20131226015941N7Phase 3Completed

Sponsor
Kerman University of Medical Sciences
Start
May 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of fentanyl in chest injury (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoint: Pain score at 20 minutes. Started May 2019; status: completed.

02

Drugs

fentanyl
03

Conditions

chest injury

Beyond the preview

Go deeper on IRCT20131226015941N7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20131226015941N7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call